Tadalafil
09-2326
Phase 3 small_molecule completed
Quick answer
Tadalafil for Pulmonary Hypertension is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Pulmonary Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed